Ali Faraz
Insider CIK 1667937 · RGNX Chief Business Officer · TNYA Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2026-09-10 | 2026-09-11 | 732,500 | — | $0 | 732,500 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2026-09-10 | 2026-09-11 | 122,000 | — | $0 | 539,782 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2026-09-10 | 2026-09-11 | 732,500 | — | $0 | 732,500 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2026-09-10 | 2026-09-11 | 122,000 | — | $0 | 539,782 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 3,969 | $0.71 | $2.8K | 430,208 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 5,837 | $0.71 | $4.1K | 434,177 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 7,406 | $0.71 | $5.3K | 417,782 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 5,020 | $0.71 | $3.6K | 425,188 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 7,406 | $0.71 | $5.3K | 417,782 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 5,020 | $0.71 | $3.6K | 425,188 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 3,969 | $0.71 | $2.8K | 430,208 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-17 | 5,837 | $0.71 | $4.1K | 434,177 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-05-18 | 2026-05-19 | 3,390 | $0.79 | $2.7K | 440,014 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 3,979 | $0.64 | $2.5K | 448,436 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 5,851 | $0.64 | $3.7K | 452,415 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-17 | 5,032 | $0.64 | $3.2K | 443,404 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2026-02-03 | 2026-02-05 | 952,250 | — | $0 | 952,250 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2026-02-03 | 2026-02-05 | 158,600 | — | $0 | 458,266 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-17 | 3,126 | $1.33 | $4.2K | 299,666 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-18 | 4,920 | $1.25 | $6.2K | 302,792 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-18 | 3,893 | $1.25 | $4.9K | 307,712 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-18 | 5,720 | $1.25 | $7.2K | 311,605 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-05-16 | 2025-05-16 | 3,189 | $0.44 | $1.4K | 317,325 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-10 | 5,794 | $0.54 | $3.1K | 324,461 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-10 | 3,947 | $0.54 | $2.1K | 320,514 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-07 | 353,271 | — | $0 | 353,271 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-07 | 650,000 | — | $0 | 650,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | D To issuer deriv | 2025-02-06 | 2025-02-07 | 161,214 | — | $0 | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-07 | 161,214 | — | $0 | 161,214 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | D To issuer deriv | 2025-02-06 | 2025-02-07 | 401,390 | — | $0 | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-07 | 401,390 | — | $0 | 401,390 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | D To issuer deriv | 2025-02-06 | 2025-02-07 | 353,271 | — | $0 | 0 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2025-02-06 | 2025-02-07 | 34,424 | — | $0 | 330,255 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2025-02-06 | 2025-02-07 | 107,500 | — | $0 | 295,831 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-08-16 | 2024-08-16 | 3,946 | $2.89 | $11.4K | 188,331 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-08-16 | 2024-08-16 | 5,802 | $2.89 | $16.8K | 192,277 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2024-02-23 | 2024-02-27 | 505,000 | — | $0 | 505,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2024-02-23 | 2024-02-27 | 85,000 | — | $0 | 198,079 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2024-02-16 | 2024-02-16 | 6,358 | $5.86 | $37.3K | 113,079 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | S Sale | 2023-08-16 | 2023-08-18 | 5,563 | $3.81 | $21.2K | 119,437 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2023-02-15 | 2023-02-17 | 675,000 | — | $0 | 675,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award | 2023-02-15 | 2023-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2022-02-15 | 2022-02-17 | 401,390 | — | $0 | 401,390 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2017-01-04 | 2017-01-06 | 25,200 | — | $0 | 25,200 | SEC↗ |
| RGNX REGENXBIO Inc. | A Award deriv | 2016-03-02 | 2016-03-02 | 200,000 | — | $0 | 200,000 | SEC↗ |